1. Nations. World Population Prospects 2019: Highlights. In: Statistical Papers - United Nations, Department of Economic and Social Affairs, Population Division: UN; 2019. https://population.un.org/wpp/Publications/Files/WPP201 9_Highlights.pdf.
2. Johnston DS, Jelinsky SA, Bang HJ, DiCandeloro P, Wilson E, Kopf GS, Turner TT. The mouse epididymal transcriptome: transcriptional profiling of segmental gene expression in the epididymis1. Biol Reprod. 2005;73(3):404–13.
3. Sullivan R, Mieusset R. The human epididymis: its function in sperm maturation. Hum Reprod Update. 2016;22(5):574–87.
4. Schultz N, Hamra FK, Garbers DL. A multitude of genes expressed solely in meiotic or postmeiotic spermatogenic cells offers a myriad of contraceptive targets. Proc Natl Acad Sci. 2003;100(21):12201–6.
5. Johnston DS, Jelinsky SA, Zhi Y, Finger JN, Kopf GS, Wright WW. Identification of testis-specific male contraceptive targets: insights from transcriptional profiling of the cycle of the rat seminiferous epithelium and purified testicular cells. Ann N Y Acad Sci. 2007;1120(1):36–46.
6. Johnston DS, Turner TT, Finger JN, Owtscharuk TL, Kopf GS, Jelinsky SA. Identification of epididymis-specific transcripts in the mouse and rat by transcriptional profiling. Asian J Androl. 2007;9(4):522–7.
7. Jelinsky SA, Turner TT, Bang HJ, Finger JN, Solarz MK, Wilson E, Brown EL, Kopf GS, Johnston DS. The rat epididymal transcriptome: comparison of segmental gene expression in the rat and mouse epididymides1. Biol Reprod. 2007;76(4):561–70.
8. Johnston DS, Wright WW, DiCandeloro P, Wilson E, Kopf GS, Jelinsky SA. Stage-specific gene expression is a fundamental characteristic of rat spermatogenic cells and Sertoli cells. Proc Natl Acad Sci. 2008;105(24):8315–20.
9. Djureinovic D, Fagerberg L, Hallström B, Danielsson A, Lindskog C, Uhlén M, Pontén F. The human testis-specific proteome defined by transcriptomics and antibody-based profiling. MHR. 2014;20(6):476–88.
10. Kent K, Johnston M, Strump N, Garcia TX. Toward development of the male pill: a decade of potential non-hormonal contraceptive targets. Front Cell Dev Biol. 2020;8:61.
11. O'Rand MG, Widgren EE, Hamil KG, Silva EJ, Richardson RT. Epididymal protein targets: a brief history of the development of epididymal protease inhibitor as a contraceptive. J Androl. 2011;32(6):698–704.
12. Archambeault DR, Matzuk MM. Disrupting the male germ line to find infertility and contraception targets. Ann Endocrinol. 2014;75(2):101–8.
13. Murdoch FE, Goldberg E. Male contraception: another holy grail. Bioorg Med Chem Lett. 2014;24(2):419–24.
14. Payne C, Goldberg E. Male contraception: past, present and future. Curr Mol Pharmacol. 2015;7(2):175–81.
15. Alves M, Dias T, Silva B, Oliveira P. Metabolic cooperation in testis as a pharmacological target: from disease to contraception. Curr Mol Pharmacol. 2015;7(2):83–95.
16. O'Rand MG, Silva EJR, Hamil KG. Non-hormonal male contraception: a review and development of an Eppin based contraceptive. Pharmacol Ther. 2016;157:105–11.
17. Chen S-R, Batool A, Wang Y-Q, Hao X-X, Chang C-S, Cheng CY, Liu Y-X. The control of male fertility by spermatid-specific factors: searching for contraceptive targets from spermatozoon’s head to tail. Cell Death Dis. 2016;7(11):–e2472.
18. Drevet JR: Epididymal approaches to male contraception. Basic Clin Androl. Basic Clin Androl. 2018;6(28):12.
19. Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57–74.
20. Zimmermann C, Stévant I, Borel C, Conne B, Pitetti J-L, Calvel P, Kaessmann H, Jégou B, Chalmel F, Nef S. Research resource: the dynamic transcriptional profile of Sertoli cells during the progression of spermatogenesis. Mol Endocrinol. 2015;29(4):627–42.
21. Browne JA, Yang R, Leir S-H, Eggener SE, Harris A. Expression profiles of human epididymis epithelial cells reveal the functional diversity of caput, corpus and cauda regions. Mol Hum Reprod. 2015;22(2):69–82.
22. da Cruz I, Rodríguez-Casuriaga R, Santiñaque FF, Farías J, Curti G, Capoano CA, Folle GA, Benavente R, Sotelo-Silveira JR, Geisinger A: Transcriptome analysis of highly purified mouse spermatogenic cell populations: gene expression signatures switch from meiotic-to postmeiotic-related processes at pachytene stage. BMC Genomics. BMC Genomics. 2016;19(17):294.
23. Zhu Z, Li C, Yang S, Tian R, Wang J, Yuan Q, Dong H, He Z, Wang S, Li Z: Dynamics of the transcriptome during human spermatogenesis: predicting the potential key genes regulating male gametes generation. Sci Rep. 2016;6:19069.
24. Guo J, Grow EJ, Yi C, Mlcochova H, Maher GJ, Lindskog C, Murphy PJ, Wike CL, Carrell DT, Goriely A, et al. Chromatin and single-cell RNA-seq profiling reveal dynamic signaling and metabolic transitions during human spermatogonial stem cell development. Cell Stem Cell. 2017;21(4):533–546.e536.
25. Helsel AR, Yang Q-E, Oatley MJ, Lord T, Sablitzky F, Oatley JM. ID4 levels dictate the stem cell state in mouse spermatogonia. Development. 2017; 144(4):624–34.
26. Kumar A, Jovel J, Lopez-Orozco J, Limonta D, Airo AM, Hou S, Stryapunina I, Fibke C, Moore RB, Hobman TC: Human Sertoli cells support high levels of Zika virus replication and persistence. Sci Rep. 2018;8(1):5477.
27. Nguyen D-T, Mathias S, Bologa C, Brunak S, Fernandez N, Gaulton A, Hersey A, Holmes J, Jensen LJ, Karlsson A, et al. Pharos: collating protein information to shed light on the druggable genome. Nucleic Acids Res. 2016;45(D1):D995–D1002.
28. Smith CL, Blake JA, Kadin JA, Richardson JE, Bult CJ. Mouse Genome Database (MGD)-2018: knowledgebase for the laboratory mouse. Nucleic Acids Res. 2017;46(D1):D836–42.
29. Zerbino DR, Achuthan P, Akanni W, Amode MR, Barrell D, Bhai J, Billis K, Cummins C, Gall A, Girón CG, et al. Ensembl 2018. Nucleic Acids Res. 2017; 46(D1):D754–61.
30. Fagerberg L, Hallström BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, Habuka M, Tahmasebpoor S, Danielsson A, Edlund K, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2013; 13(2):397–406.
31. Dickinson ME, Flenniken AM, Ji X, Teboul L, Wong MD, White JK, Meehan TF, Weninger WJ, Westerberg H, Adissu H, et al. High-throughput discovery of novel developmental phenotypes. Nature. 2016;537(7621):508–14.
32. Heinrich G, Ghosh S, DeAngelis AM, Schroeder-Gloeckler JM, Patel PR, Castaneda TR, Jeffers S, Lee AD, Jung DY, Zhang Z, et al. Carcinoembryonic antigen-related cell adhesion molecule 2 controls energy balance and peripheral insulin action in mice. Gastroenterology. 2010;139(2):644–652.e641.
33. Nagaishi T, Pao L, Lin S-H, Iijima H, Kaser A, Qiao S-W, Chen Z, Glickman J, Najjar SM, Nakajima A, et al. SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. Immunity. 2006;25(5):769–81.
34. Leung N, Turbide C, Olson M, Marcus V, Jothy S, Beauchemin N. Deletion of the carcinoembryonic antigen-related cell adhesion molecule 1 (Ceacam1) gene contributes to colon tumor progression in a murine model of carcinogenesis. Oncogene. 2006;25(40):5527–36.
35. Hemmila E, Turbide C, Olson M, Jothy S, Holmes KV, Beauchemin N. Ceacam1a-/- mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59. J Virol. 2004;78(18):10156–65.
36. Finkenzeller D, Fischer B, Lutz S, Schrewe H, Shimizu T, Zimmermann W. Carcinoembryonic antigen-related cell adhesion molecule 10 expressed specifically early in pregnancy in the decidua is dispensable for normal murine development. Mol Cell Biol. 2003;23(1):272–9.
37. Birk OS, Casiano DE, Wassif CA, Cogliati T, Zhao L, Zhao Y, Grinberg A, Huang S, Kreidberg JA, Parker KL, et al. The LIM homeobox gene Lhx9 is essential for mouse gonad formation. Nature. 2000;403(6772):909–13.
38. Balasubramanian R, Bui A, Xie X, Deng M, Gan L. Generation and characterization ofLhx9-GFPCreERT2knock-in mouse line. genesis. 2014;52(9):827–32.
39. Chapman Karen M, Medrano Gerardo A, Jaichander P, Chaudhary J, Waits Alexandra E, Nobrega Marcelo A, Hotaling James M, Ober C, Hamra FK. Targeted germline modifications in rats using CRISPR/Cas9 and spermatogonial stem cells. Cell Rep. 2015;10(11):1828–35.
40. Bellve AR, Cavicchia JC, Millette CF, O'Brien DA, Bhatnagar YM, Dym M. Spermatogenic cells of the prepuberal mouse. Isolation and morphological characterization. J Cell Biol. 1977;74(1):68–85.
41. Choi E, Lee J, Oh J, Park I, Han C, Yi C, Kim DH, Cho BN, Eddy EM, Cho C. Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library. BMC Genomics. 2007;8:256.
42. Liu F, Jin S, Li N, Liu X, Wang H, Li J. Comparative and functional analysis of testis-specific genes. Biol Pharm Bull. 2011;34(1):28–35.
43. Miyata H, Castaneda JM, Fujihara Y, Yu Z, Archambeault DR, Isotani A, Kiyozumi D, Kriseman ML, Mashiko D, Matsumura T, et al. Genome engineering uncovers 54 evolutionarily conserved and testis-enriched genes that are not required for male fertility in mice. Proc Natl Acad Sci. 2016; 113(28):7704–10.
44. Wells JA, McClendon CL. Reaching for high-hanging fruit in drug discovery at protein–protein interfaces. Nature. 2007;450(7172):1001–9.
45. Olson CM, Jiang B, Erb MA, Liang Y, Doctor ZM, Zhang Z, Zhang T, Kwiatkowski N, Boukhali M, Green JL, et al. Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation. Nat Chem Biol. 2017; 14(2):163–70.
46. Bondeson DP, Mares A, Smith IED, Ko E, Campos S, Miah AH, Mulholland KE, Routly N, Buckley DL, Gustafson JL, et al. Catalytic in vivo protein knockdown by small-molecule PROTACs. Nat Chem Biol. 2015;11(8):611–7.
47. Lu J, Qian Y, Altieri M, Dong H, Wang J, Raina K, Hines J, Winkler James D, Crew Andrew P, Coleman K, et al. Hijacking the E3 ubiquitin ligase cereblon to efficiently target BRD4. Chem Biol. 2015;22(6):755–63.
48. Bondeson DP, Smith BE, Burslem GM, Buhimschi AD, Hines J, Jaime- Figueroa S, Wang J, Hamman BD, Ishchenko A, Crews CM. Lessons in PROTAC design from selective degradation with a promiscuous warhead. Cell Chem Biol. 2018;25(1):78–87.e75.
49. Ottis P, Toure M, Cromm PM, Ko E, Gustafson JL, Crews CM. Assessing different E3 ligases for small molecule induced protein ubiquitination and degradation. ACS Chem Biol. 2017;12(10):2570–8.
50. Bechara C, Sagan S. Cell-penetrating peptides: 20 years later, where do we stand? FEBS Lett. 2013;587(12):1693–702.
51. Brooks H, Lebleu B, Vives E. Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev. 2005;57(4):559–77.
52. Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson A, Kampf C, Sjostedt E, Asplund A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.
53. Tanaka H, Hirose M, Tokuhiro K, Matsuoka Y, Miyagawa Y, Tsujimura A, Okuyama A, Nishimune Y. Single nucleotide polymorphisms: discovery of the genetic causes of male infertility. Soc Reprod Fertil Suppl. 2007;65:531–4.
54. Visser L, Westerveld GH, Xie F, van Daalen SK, van der Veen F, Lombardi MP, Repping S. A comprehensive gene mutation screen in men with asthenozoospermia. Fertil Steril. 2011;95(3):1020–1024 e1021–1029.
55. Rappaport N, Twik M, Plaschkes I, Nudel R, Iny Stein T, Levitt J, Gershoni M, Morrey CP, Safran M, Lancet D. MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search. Nucleic Acids Res. 2017;45(D1):D877–87.
56. Okutman O, Rhouma MB, Benkhalifa M, Muller J, Viville S. Genetic evaluation of patients with non-syndromic male infertility. J Assist Reprod Genet. 2018; 35(11):1939–51.
57. Robay A, Abbasi S, Akil A, El-Bardisi H, Arafa M, Crystal RG, Fakhro KA. A systematic review on the genetics of male infertility in the era of next- generation sequencing. Arab J Urol. 2018;16(1):53–64.
58. Krausz C, Escamilla AR, Chianese C. Genetics of male infertility: from research to clinic. Reproduction. 2015;150(5):R159–74.
59. Plaseski T, Noveski P, Popeska Z, Efremov GD, Plaseska-Karanfilska D. Association study of single-nucleotide polymorphisms in FASLG, JMJDIA, LOC203413, TEX15, BRDT, OR2W3, INSR, and TAS2R38 genes with male infertility. J Androl. 2012;33(4):675–83.
60. Aston KI, Krausz C, Laface I, Ruiz-Castane E, Carrell DT. Evaluation of 172 candidate polymorphisms for association with oligozoospermia or azoospermia in a large cohort of men of European descent. Hum Reprod. 2010;25(6):1383–97.
61. Fakhro KA, Elbardisi H, Arafa M, Robay A, Rodriguez-Flores JL, Al-Shakaki A, Syed N, Mezey JG, Abi Khalil C, Malek JA, et al. Point-of-care whole-exome sequencing of idiopathic male infertility. Genet Med. 2018;20(11):1365–73.
62. Matzuk MM, Lamb DJ. The biology of infertility: research advances and clinical challenges. Nat Med. 2008;14(11):1197–213.
63. Zhang W, Zhang S, Xiao C, Yang Y, Zhoucun A. Mutation screening of the FKBP6 gene and its association study with spermatogenic impairment in idiopathic infertile men. Reproduction. 2007;133(2):511–6.
64. Du R, Lu C, Jiang Z, Li S, Ma R, An H, Xu M, An Y, Xia Y, Jin L, et al. Efficient typing of copy number variations in a segmental duplication-mediated rearrangement hotspot using multiplex competitive amplification. J Hum Genet. 2012;57(8):545–51.
65. Ghieh F, Mitchell V, Mandon-Pepin B, Vialard F. Genetic defects in human azoospermia. Basic Clin Androl. 2019;29:4.
66. Irie S, Tsujimura A, Miyagawa Y, Ueda T, Matsuoka Y, Matsui Y, Okuyama A, Nishimune Y, Tanaka H. Single-nucleotide polymorphisms of the PRDM9 (MEISETZ) gene in patients with nonobstructive azoospermia. J Androl. 2009;30(4):426–31.
67. Miyamoto T, Koh E, Sakugawa N, Sato H, Hayashi H, Namiki M, Sengoku K. Two single nucleotide polymorphisms in PRDM9 (MEISETZ) gene may be a genetic risk factor for Japanese patients with azoospermia by meiotic arrest. J Assist Reprod Genet. 2008;25(11–12):553–7.
68. Minase G, Miyamoto T, Miyagawa Y, Iijima M, Ueda H, Saijo Y, Namiki M, Sengoku K. Single-nucleotide polymorphisms in the human RAD21L gene may be a genetic risk factor for Japanese patients with azoospermia caused by meiotic arrest and Sertoli cell-only syndrome. Hum Fertil (Camb). 2017; 20(3):217–20.
69. Li Z, Huang Y, Li H, Hu J, Liu X, Jiang T, Sun G, Tang A, Sun X, Qian W, et al. Excess of rare variants in genes that are key epigenetic regulators of spermatogenesis in the patients with non-obstructive azoospermia. Sci Rep. 2015;5:8785.
70. Choi Y, Jeon S, Choi M, Lee MH, Park M, Lee DR, Jun KY, Kwon Y, Lee OH, Song SH, et al. Mutations in SOHLH1 gene associate with nonobstructive azoospermia. Hum Mutat. 2010;31(7):788–93.
71. Dacheux D, Roger B, Bosc C, Landrein N, Roche E, Chansel L, Trian T, Andrieux A, Papaxanthos-Roche A, Marthan R, et al. Human FAM154A (SAXO1) is a microtubule-stabilizing protein specific to cilia and related structures. J Cell Sci. 2015;128(7):1294–307.
72. Wang D, Zou L, Jin Q, Hou J, Ge G, Yang L. Human carboxylesterases: a comprehensive review. Acta Pharm Sin B. 2018;8(5):699–712.
73. Hosokawa M. Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs. Molecules. 2008;13(2):412–31.
74. Ross MK, Crow JA. Human carboxylesterases and their role in xenobiotic and endobiotic metabolism. J Biochem Mol Toxicol. 2007;21(4):187–96.
75. Satoh T, Hosokawa M. The mammalian carboxylesterases: from molecules to functions. Annu Rev Pharmacol Toxicol. 1998;38:257–88.
76. Alam M, Ho S, Vance DE, Lehner R. Heterologous expression, purification, and characterization of human triacylglycerol hydrolase. Protein Expr Purif. 2002;24(1):33–42.
77. Xu J, Li Y, Chen WD, Xu Y, Yin L, Ge X, Jadhav K, Adorini L, Zhang Y. Hepatic carboxylesterase 1 is essential for both normal and farnesoid X receptor- controlled lipid homeostasis. Hepatology. 2014;59(5):1761–71.
78. Quiroga AD, Li L, Trotzmuller M, Nelson R, Proctor SD, Kofeler H, Lehner R. Deficiency of carboxylesterase 1/esterase-x results in obesity, hepatic steatosis, and hyperlipidemia. Hepatology. 2012;56(6):2188–98.
79. Zhang L, Liu Q, Zhou Y, Zhang Y. Baculo-expression and enzymatic characterization of CES7 esterase. Acta Biochim Biophys Sin Shanghai. 2009; 41(9):731–6.
80. Rejraji H, Sion B, Prensier G, Carreras M, Motta C, Frenoux JM, Vericel E, Grizard G, Vernet P, Drevet JR. Lipid remodeling of murine epididymosomes and spermatozoa during epididymal maturation. Biol Reprod. 2006;74(6):1104–13.
81. Parks JE, Hammerstedt RH. Development changes occurring in the lipids of ram epididymal spermatozoa plasma membrane. Biol Reprod. 1985;32(3):653–68.
82. Lin Y, Kan FW. Regionalization and redistribution of membrane phospholipids and cholesterol in mouse spermatozoa during in vitro capacitation. Biol Reprod. 1996;55(5):1133–46.
83. Hoshi K, Aita T, Yanagida K, Yoshimatsu N, Sato A. Variation in the cholesterol/phospholipid ratio in human spermatozoa and its relationship with capacitation. Hum Reprod. 1990;5(1):71–4.
84. Mitra A, Richardson RT, O'Rand MG. Analysis of recombinant human semenogelin as an inhibitor of human sperm motility. Biol Reprod. 2010; 82(3):489–96.
85. Wang Z, Widgren EE, Richardson RT, O'Rand MG. Characterization of an eppin protein complex from human semen and spermatozoa. Biol Reprod. 2007;77(3):476–84.
86. Yenugu S, Richardson RT, Sivashanmugam P, Wang Z, O’Rand MG, French FS, Hall SH. Antimicrobial activity of human EPPIN, an androgen-regulated, sperm-bound protein with a whey acidic protein motif. Biol Reprod. 2004; 71(5):1484–90.
87. Tanabe LM, List K. The role of type II transmembrane serine protease- mediated signaling in cancer. FEBS J. 2017;284(10):1421–36.
88. Szabo R, Lantsman T, Peters DE, Bugge TH. Delineation of proteolytic and non-proteolytic functions of the membrane-anchored serine protease prostasin. Development. 2016;143(15):2818–28.
89. Kawaguchi M, Kataoka H. Mechanisms of hepatocyte growth factor activation in cancer tissues. Cancers (Basel). 2014;6(4):1890–904.
90. Szabo R, Hobson JP, Christoph K, Kosa P, List K, Bugge TH. Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice. Development. 2009; 136(15):2653–63.
91. Clauss A, Persson M, Lilja H, Lundwall A. Three genes expressing Kunitz domains in the epididymis are related to genes of WFDC-type protease inhibitors and semen coagulum proteins in spite of lacking similarity between their protein products. BMC Biochem. 2011;12:55.
92. Noda T, Lu Y, Fujihara Y, Oura S, Koyano T, Kobayashi S, Matzuk MM, Ikawa M. Sperm proteins SOF1, TMEM95, and SPACA6 are required for sperm- oocyte fusion in mice. Proc Natl Acad Sci U S A. 2020;117(21):11493–502.
93. Fujihara Y, Noda T, Kobayashi K, Oji A, Kobayashi S, Matsumura T, Larasati T, Oura S, Kojima-Kita K, Yu Z, et al. Identification of multiple male reproductive tract-specific proteins that regulate sperm migration through the oviduct in mice. Proc Natl Acad Sci U S A. 2019;116(37):18498–506.
94. Yamaguchi R, Muro Y, Isotani A, Tokuhiro K, Takumi K, Adham I, Ikawa M, Okabe M. Disruption of ADAM3 impairs the migration of sperm into oviduct in mouse. Biol Reprod. 2009;81(1):142–6.
95. Shamsadin R, Adham IM, Nayernia K, Heinlein UA, Oberwinkler H, Engel W. Male mice deficient for germ-cell cyritestin are infertile. Biol Reprod. 1999; 61(6):1445–51.
96. Fujihara Y, Oji A, Kojima-Kita K, Larasati T, Ikawa M: Co-expression of sperm membrane proteins CMTM2A and CMTM2B is essential for ADAM3 localization and male fertility in mice. J Cell Sci 2018, 131(19).
97. Fujihara Y, Miyata H, Ikawa M. Factors controlling sperm migration through the oviduct revealed by gene-modified mouse models. Exp Anim. 2018; 67(2):91–104.
98. Tutar Y. Pseudogenes. Comp Funct Genomics. 2012;2012:424526.
99. An Y, Furber KL, Ji S. Pseudogenes regulate parental gene expression via ceRNA network. J Cell Mol Med. 2017;21(1):185–92.
100. Burgio G, Szatanik M, Guenet JL, Arnau MR, Panthier JJ, Montagutelli X. Interspecific recombinant congenic strains between C57BL/6 and mice of the Mus spretus species: a powerful tool to dissect genetic control of complex traits. Genetics. 2007;177(4):2321–33.
101. Leinonen R, Sugawara H, Shumway M. The Sequence Read Archive. Nucleic Acids Res. 2010;39(Database):D19–21.
102. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnetjournal. 2011;17(1):10.
103. Pertea M, Kim D, Pertea GM, Leek JT, Salzberg SL. Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. Nature Protocols. 2016;11(9):1650–67.
104. Chim S, Wong K, Chung C, Lam S, Kwok J, Lai C-Y, Cheng Y, Hui A, Meng M, Chan O-K, et al. Systematic selection of reference genes for the normalization of circulating RNA transcripts in pregnant women based on RNA-seq data. Int J Mol Sci. 2017;18(8):1709.
105. Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2013;30(7):923–30.
106. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009;26(1):139–40.
107. Oji A, Noda T, Fujihara Y, Miyata H, Kim YJ, Muto M, Nozawa K, Matsumura T, Isotani A, Ikawa M. CRISPR/Cas9 mediated genome editing in ES cells and its application for chimeric analysis in mice. Sci Rep. 2016;6:31666.
論文の公開元へ
